A Phase II Trial of CNCT19 Cell Injection for the Treatment of CD19-Positive Relapse/Refractory Acute Lymphoblastic Leukemia
| Title | A Phase II Trial of CNCT19 Cell Injection for the Treatment of CD19-Positive Relapse/Refractory Acute Lymphoblastic Leukemia |
|---|---|
| Description | A Phase II Trial of CNCT19 Cell Injection for the Treatment of CD19-Positive Relapse/Refractory Acute Lymphoblastic Leukemia |
| Organism | Homo sapiens |
| Data Type | Other Type of Clinical information |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA016022 |
| Release Date | 2023-04-07 |
| Submitter | Yinling Wu (wuyinling@juventas.cn) |
| Organization | Heyuan Biotechnology (Tianjin) limited company |
| Submission Date | 2023-04-06 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX003660-01 | Clinical data - general laboratory test information | 87 | Other Type of Clinical information | 5.0 MB | xlsx | 0 | Controlled |
| OMIX003660-02 | Clinical data - disease evaluation, drug combinations, adverse events, etc | 87 | Other Type of Clinical information | 2.8 MB | xlsx | 0 | Controlled |